Table 2.
Groups | I-baseline | I-lesion | I-post | |
---|---|---|---|---|
Peptide | P/I |
1039.78 Aa ±67.45 |
205.57 Ca ±13.86 |
803.79 Bb ±63.11 |
P/II |
1101.08 Aa ±77.12 |
200.45 Ca ±6.34 |
894.50 Ba ±18.89 |
|
P/III |
1014.96 Aa ±55.10 |
201.36 Ca ±9.82 |
707.17 Bc ±24.69 |
|
P/AS |
1007.68 Aa ±59.03 |
197.35 Ca ± 9.46 |
491.38 Bd ±26.37 |
|
Non-Peptide | NP/I |
1032.34 Aa ±49.99 |
205.93Ca ± 11.11 |
473.01 Bd ±16.34 |
NP/II |
1012.79 Aa ±35.31 |
200.96 Ca ±9.43 |
695.33 Bc ±30.61 |
|
NP/III |
1051.22 Aa ±59.12 |
202.57 Ca ±11.55 |
409.92 Be ±12.69 |
|
NP/AS |
1025.61 Aa ±61.41 |
200.05 Ca ±10.00 |
218.29 Bf ±10.65 |
Results of two-way repeated measures ANOVA and Bonferroni-corrected post hoc test for pairwise multiple comparisons. Different uppercase and lowercase superscript letters indicate significant differences among the same raw and column, respectively at P <0.05